Search by Journal
- HOME
- > Search by Journal
- > International Journal of Myeloma
International Journal of Myeloma
Volume , Issue suppl / 2010


- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
![]() |
The 35th Japan myeloma meeting for the study general meeting chairperson greetings 吉田喬 International Journal of Myeloma (suppl): 3-3, 2010. |
---|
![]() |
Bony lesion management of the SC-1 multiple myeloma 安倍正博 International Journal of Myeloma (suppl): 25-25, 2010. |
---|
![]() |
LS-1 The impact of new drugs in the high dose strategy Michel Attal International Journal of Myeloma (suppl): 26-27, 2010. |
---|
![]() |
SL-1 Role of Cytogenetic Abnormalities for Myeloma Treatment Herve AVET-LOISEAU International Journal of Myeloma (suppl): 28-28, 2010. |
---|
![]() |
SL-2 The chronic therapy paradigm for multiple myeloma Mohamad Hussein International Journal of Myeloma (suppl): 29-29, 2010. |
---|
![]() |
A new drug and appropriate management procedure 日本骨髄腫研究会 International Journal of Myeloma (suppl): 33-33, 2010. |
---|
![]() |
Mouth care of patients with cancer 日本骨髄腫研究会 International Journal of Myeloma (suppl): 34-34, 2010. |
---|
![]() |
From the situation of the CS2-1 physician 尾崎修治 International Journal of Myeloma (suppl): 35-35, 2010. |
---|
![]() |
From the situation of CS2-2 oral surgery 丸岡豊 International Journal of Myeloma (suppl): 36-36, 2010. |
---|
![]() |
CS2-3 From the standpoint of a dental hygienist "For the patient. - What we can do - " Oral care of cancer patients 中川裕美子 International Journal of Myeloma (suppl): 37-37, 2010. |
---|
![]() |
What we can perform in management - now of peripheral neuropathy! - 日本骨髄腫研究会 International Journal of Myeloma (suppl): 38-38, 2010. |
---|
![]() |
Role - of the physician in peripheral neuropathy - team approach in medical care by the CS3-1 bortezomib 磯田淳 International Journal of Myeloma (suppl): 39-39, 2010. |
---|
![]() |
Make an efforts - observation list and the template by the team corresponding to peripheral neuropathy with the CS3-2 bortezomib treatment; and ... 岡田静香1, 峯友梢1, 浴野瞳1, 細谷成裕1, 奈良田絢香1, 倉持玲子1, 中山優子1, 吉田祐子1, 伊藤歩2, 臼杵憲祐2, 高野浩彦3 International Journal of Myeloma (suppl): 40-40, 2010. |
---|
![]() |
Attempt of the manual preparation of nosocomial peripheral neuropathy measures in the CS3-3 bortezomib treatment 平井三保子1, 渡邊光正2, 志智早織1, 東海林絵美1, 大西和也1, 山田邦義1, 石津雅弘1, 通堂満2 International Journal of Myeloma (suppl): 41-41, 2010. |
---|
![]() |
Than examination - questionnaire results for peripheral neuropathy (numbness) by the CS3-4 bortezomib grasp and correspondence ... of initial symptoms for the numbness of the patients 吉田弘子, 冨田章代, 宮田美香子, 田村乃莉子, 前澤洋子, 吉田喬 International Journal of Myeloma (suppl): 42-42, 2010. |
---|
![]() |
Basic study for the onset prevention of the A-1 multiple myeloma 幸谷愛1,2, Bidisha Chanda1, 川俣豊隆1, 豊嶋孝恵1, 佐藤磨実子3, 東條有伸1,2 International Journal of Myeloma (suppl): 44-44, 2010. |
---|
![]() |
The antimyeloma effect of the A-2 bortezomib goes through expression of piston deacetylase inhibition 菊池次郎1, 和田妙子1, 清水瑠美1, 和泉透2, 光永佳奈枝1, 畑野かおる3, 信吉正治1, 小澤敬也3, 加納康彦2, 古川雄祐1,3 International Journal of Myeloma (suppl): 44-44, 2010. |
---|
![]() |
Participation in dexamethasone sensitivity of the exhaustive screening of the DNA methylation gene in the A-3 multiple myeloma and the RASD1 gene methylation 青木由佳1, 野島正寛2, 安井寛1,3, 丸山玲緒1, 多羅澤功1, 池田博1, 鈴木拓1,3, 林敏昭1, 酒井基4, 麻奥英毅5, 石田禎夫1, 豊田実3, 篠村恭久1 International Journal of Myeloma (suppl): 45-45, 2010. |
---|
![]() |
TRAIL onset of A-4 myeloma and bone allied event 河野和1, 上野志貴子1, 菊川佳敬1, 猪山賢一2, 奥野豊1, 満屋裕明1, 畑裕之1 International Journal of Myeloma (suppl): 45-45, 2010. |
---|
![]() |
TRAIL of myeloma cells by A-5 Bortezomib-sensitive sthenia 三木浩和1, 安倍正博1, 崔衢1, 渡邊佳一郎2, 池亀彰茂1, 原田武志1, 藤井志朗1, 中村信元1, 中野綾子1, 賀川久美子1, 竹内恭子1, 尾崎修治3, 松本俊夫1 International Journal of Myeloma (suppl): 46-46, 2010. |
---|
![]() |
Examination of the seasonal polymorphism analysis of interleukin-18 (IL-18) promoter in the B-1 multiple myeloma 斉藤貴之1,2, 星野巧臣1, 三井健揮1, 小磯博美1,2, 横濱章彦3, 半田寛1, 澤村守夫5, 唐沢正光3, 塚本憲史1,2, 村上博和4 International Journal of Myeloma (suppl): 46-46, 2010. |
---|
![]() |
What is the difference between B-2 MGUS and smoldering MM? 樽谷美保1, 坂井晃1, 板垣充弘2, 木村昭郎1 International Journal of Myeloma (suppl): 47-47, 2010. |
---|
![]() |
Clinical examination of macrocytic anemia in the B-3 multiple myeloma 板垣充弘1, 片山雄太1, 吉田雅明1, 許鴻平1, 岡谷健史1, 麻奥英毅2 International Journal of Myeloma (suppl): 47-47, 2010. |
---|
![]() |
B-4 CD125-positive myeloma: Unripe myeloma indicating the bortezomib hyposensitivity 河野和, 菊川佳敬, 満屋裕明, 畑裕之 International Journal of Myeloma (suppl): 48-48, 2010. |
---|
![]() |
Examination of the Cyclin D1-positive multiple myeloma in the B-5 our hospital 中村裕一1, 伊藤善啓1, 脇本直樹1, 掛川絵美1, 土居美枝子2, 茅野秀一2, 別所正美1 International Journal of Myeloma (suppl): 48-48, 2010. |
---|
![]() |
Examination of the usefulness of the examination for FDG-PET for the C-1 multiple myeloma case 遠山和博1, 今井陽一1, 南谷泰仁1, 高橋美和子2, 佐藤次郎2, 稲野祥子2, 山本豪1, 赤羽正章2, 百瀬敏光2, 大友邦2, 黒川峰夫1 International Journal of Myeloma (suppl): 49-49, 2010. |
---|
![]() |
Examination of the usefulness of the multiple myeloma diagnosis by Durie / Salmon PLUS staging system using the examination of C-2 PET 小杉浩史 International Journal of Myeloma (suppl): 49-49, 2010. |
---|
![]() |
A precaution in the data interpretation of the C-3 serum FLC result of a measurement and the correspondence 伊藤早織, 金田誠, 岸義郎, 新井次郎 International Journal of Myeloma (suppl): 50-50, 2010. |
---|
![]() |
C-4 Utility of Serum Free Light Chain Measurement in Monoclonal Gammopathies : Diagnosis, Monitoring and Prognosis Alison M. Levoguer International Journal of Myeloma (suppl): 51-51, 2010. |
---|
![]() |
Significance of peripheral neuropathy and the examination in the episode of care of the C-5 multiple myeloma for nerve conduction 平井理泉, 谷村聡, 高野淳一朗, 北原英晃, 塚本彩人, 木村悠子, 美山貴彦, 竹下昌孝, 萩原將太郎, 三輪哲義 International Journal of Myeloma (suppl): 52-52, 2010. |
---|
![]() |
We look at the rear of the tumor lysis syndrome with the D-1 Bortezomib therapy and analyze a mark 谷村聡, 平井理泉, 高野淳一朗, 北原英晃, 塚本彩人, 木村悠子, 美山貴彦, 竹下昌孝, 萩原将太郎, 三輪哲義 International Journal of Myeloma (suppl): 52-52, 2010. |
---|
![]() |
Examination of the establishment of the D-2 Bortezomib-resistant myeloma cell line and the resistant mechanism 李政樹1, 飯田真介1, 中嶋孝行2, 宮崎秀幸2, 塩津行正2, 森芙美子1, 伊藤旭1, 稲垣淳1, 楠本茂1, 石田高司1, 小松弘和1, 上田龍三1 International Journal of Myeloma (suppl): 53-53, 2010. |
---|
![]() |
Examination of the usefulness for the herpesvirus infection of 200 mg of aciclovir at the D-3 bortezomib medical treatment prophylactic internal use 青木智広, 西山誉大, 今橋伸彦, 北村邦朗 International Journal of Myeloma (suppl): 53-53, 2010. |
---|
![]() |
Reduction of the gastrointestinal adverse event with the D-4 Weekly bortezomib plus dexamethasone therapy 福島俊洋, 中村拓路, 岩男悠, 中島章夫, 三木美由貴, 坂井知之, 澤木俊興, 藤田義正, 田中真生, 正木康史, 廣瀬優子, 梅原久範 International Journal of Myeloma (suppl): 54-54, 2010. |
---|
![]() |
Peripheral neuropathy that aggravated onset / after bortezomib administration in the D-5 multiple myeloma 馬渡桃子, 磯田淳, 神尾直, 中橋寛隆, 松本守生, 澤村守夫 International Journal of Myeloma (suppl): 54-54, 2010. |
---|
![]() |
Examination about peripheral neuropathy in the Bortezomib therapy for the D-6 multiple myeloma 浅野豪, 黒井大雅, 小西順, 久保西四郎, 朝倉昇司, 角南一貴 International Journal of Myeloma (suppl): 55-55, 2010. |
---|
![]() |
The present conditions of the bortezomib therapy in the E-1 our hospital 若山聡雄, 池田直人, 景山康生, 吾郷浩厚 International Journal of Myeloma (suppl): 55-55, 2010. |
---|
![]() |
Hummer recurrence, examination - of -33 treatment results by the bortezomib of the intractable multiple myeloma 西村倫子, 仲野兼司, 奈良江梨子, 上田響子, 那須健太郎, 鈴木一史, 三嶋裕子, 坂尻さくら, 横山雅大, 照井康仁, 畠清彦 International Journal of Myeloma (suppl): 56-56, 2010. |
---|
![]() |
Clinical phase I study of the dexamethasone combination therapy (iPAD therapy) equivalent among bortezomib, doxorubicin for E-3 recurrence, the progress-related multiple myeloma 高松泰1, 角南一貴2, 畑裕之3, 長藤宏司4, 崔日承5, 樋口雅一6, 魚住公治7, 正木康史8, 田村和夫1 International Journal of Myeloma (suppl): 56-56, 2010. |
---|
![]() |
Multicenter randomization for transplant non-adaptation multiple myeloma (MM) in E-4 Tohoku District, fact (UMIN No. of the controlled trial 3472) 本間りこ1, 勝岡優奈2, 遠宮靖雄3, 目黒邦昭4, 木村秀夫5, 大本英次郎1, 田嶋克史6, 小川一英7, 石澤賢一2, 石田陽治8, 澤田賢一9, 張替秀郎2, TOHOKU Myeloma Study Organization International Journal of Myeloma (suppl): 57-57, 2010. |
---|
![]() |
Bell Quaid (Vel) treatment for the myeloma under E-5 Miyazaki 松岡均1,7, 河野浩1,7, 前田宏一2,7, 石崎淳三3,7, 山下清4,7, 河野徳明4,7, 吉田周郎4,7, 佐々木規5,7, 外山孝典5,7, 久冨木庸子6,7, 下田和也6,7 International Journal of Myeloma (suppl): 57-57, 2010. |
---|
![]() |
Effect of Bortezomib on multiple myeloma having E-6 marrow ectoplasm androblastoma 神尾直, 中橋寛隆, 馬渡桃子, 磯田淳, 松本守生, 澤村守夫 International Journal of Myeloma (suppl): 58-58, 2010. |
---|
![]() |
Reinforcement effect of the antimyeloma activity of γ δ T cell by F-1 Lenalidomide and the zoledronic acid 崔衢1, 安倍正博1, 三木浩和1, 中村信元1, 藤井志朗1, 原田武志1, 中野綾子1, 賀川久美子1, 竹内恭子1, 尾崎修治2, 松本俊夫1 International Journal of Myeloma (suppl): 58-58, 2010. |
---|
![]() |
lenalidomide+dexamethasone therapy for the F-2 treatment-resistant multiple myeloma 松本守生1, 馬渡桃子1, 神尾直1, 中橋寛隆1, 磯田淳1, 澤村守夫2, 村上博和3 International Journal of Myeloma (suppl): 59-59, 2010. |
---|
![]() |
Experience of the treatment with lenalidomide for the F-3 myeloma 松岡均, 河野浩 International Journal of Myeloma (suppl): 59-59, 2010. |
---|
![]() |
Lenalidomide for the treatment-resistant multiple myeloma in the F-4 our hospital, histories of treatment of the dexamethasone therapy 岡野晃, 淵田真一, 初瀬真弓, 村頭智, 島崎千尋 International Journal of Myeloma (suppl): 60-60, 2010. |
---|
![]() |
Five cases of the intractable multiple myeloma that showed early reaction in F-5 Revlimid (R) 堀光雄1, 飯塚聡介1, 太田昌一郎2, 三橋彰一2, 小島寛2 International Journal of Myeloma (suppl): 60-60, 2010. |
---|
![]() |
Examination of the impaired renal function improvement effect of the Bortezomib, Dexamethasone therapy on multiple myeloma F-6 serum creatinine level 2 mg/dl or more 芳賀光洋, 関口直宏, 永田明久, 能登俊, 竹迫直樹 International Journal of Myeloma (suppl): 61-61, 2010. |
---|
![]() |
Analysis - by myeloma cells kidney permeation - autopsy case for the multiple myeloma with the G-1 renal failure 高野淳一朗1, 田頭周2, 望月眞2, 北原英晃1, 木村悠子1, 塚本彩人1, 美山貴彦1, 竹下昌孝1, 平井理泉1, 谷村聡1, 萩原将太郎1, 三輪哲義1 International Journal of Myeloma (suppl): 61-61, 2010. |
---|
![]() |
Histories of treatment of the plasma cell leukemia in the G-2 our hospital 新井康之, 杉浦弘幸, 松井宏行, 森分智子, 城友泰, 上田智朗, 岡田和也, 河田岳人, 前田猛, 大西達人, 水谷知里, 松山文男, 上田恭典 International Journal of Myeloma (suppl): 62-62, 2010. |
---|
![]() |
1 case of the multiple myeloma with the huge bony lesion that G-3 endoxan, bell Quaid, three-drug chemotherapy of the dexamethasone succeeded 八木秀男, 藤田茉莉子, 飯塚隆史, 山崎佳子, 花本仁, 椿和央 International Journal of Myeloma (suppl): 62-62, 2010. |
---|
![]() |
1 case that thalidomide was effective for G-4-prone marrow ectoplasm androblastoma 小磯博美1,2, 横濱章彦3, 斉藤貴之1,2, 半田寛1, 塚本憲史2, 村上博和4 International Journal of Myeloma (suppl): 63-63, 2010. |
---|
![]() |
An example of the multiple myeloma that recurred as a tumor in the orbit all over the course when G-5 MP therapy was effective, and normal marrow was obtained 米田美栄, 小泉正幸, 石井昭広 International Journal of Myeloma (suppl): 63-63, 2010. |
---|
![]() |
Examination of two multiple myeloma that presented H-1 HBV reactivation 伊藤薫樹, 菅原健, 村井一範, 石田陽治 International Journal of Myeloma (suppl): 64-64, 2010. |
---|
![]() |
One case of the pulmonary Mucormycosis that had difficulty in pulmonary disorder and differentiation by the H-2 bortezomib 崔日承1, 宮下要1, 末廣陽子1, 田口健一2, 鵜池直邦1 International Journal of Myeloma (suppl): 64-64, 2010. |
---|
![]() |
IgE - κ type multiple myeloma that presented H-3 t (11, 14), and got Bortezomib resistance in a short term 甲田祐也, 横山明弘, 籠尾壽哉, 大橋晃太, 細田亮, 工藤昌尚, 上野博則, 朴載源, 矢野尊啓 International Journal of Myeloma (suppl): 65-65, 2010. |
---|
![]() |
One case of the MGUS in acknowledgment of H-4 Crystalglobulinemia 八幡悠里子1, 佐々木純1, 細根勝2, 小松則夫1 International Journal of Myeloma (suppl): 65-65, 2010. |
---|
![]() |
An example of the alpha chain disease that was not able to detect H-5 M protein 栗本美和1, 島貫栄弥1, 細井裕樹1, 村田祥吾1, 花岡伸佳1, 畑中一生1, 前田義政2, 中村靖3, 園木孝志1, 中熊秀喜1 International Journal of Myeloma (suppl): 66-66, 2010. |
---|
![]() |
Examination about nine primary amyloidosis which we experienced in I-1 our hospital 奥山奈美子, 田村秀人, 近藤麻加, 檀和夫, 緒方清行 International Journal of Myeloma (suppl): 66-66, 2010. |
---|
![]() |
Histories of treatment by bortezomib of the I-2 AL amyloidosis merger myeloma 2 case 和泉透, 西川彰則, 角田三郎, 田中勝, 阿久津美百生, 加納康彦 International Journal of Myeloma (suppl): 67-67, 2010. |
---|
![]() |
Clinical examination of 46 AL amyloidosis in our hospital in I-3 five years 林さやか, 小澤瑶子, 川辺美穂, 森田剣, 飯塚浩光, 西山小百合, 阿部有, 関根理恵子, 中川靖章, 鈴木憲史 International Journal of Myeloma (suppl): 67-67, 2010. |
---|
![]() |
Attempt of peripheral blood stem cell sampling (PBSCC) by the low-dose endoxan (Low dose-CY, LD-CY), G-CSF combination in I-4 multiple myeloma (MM) 志村勇司1, 黒田純也1, 古林勉1, 堤康彦1, 山下美穂子1, 大城宗生1, 山本未央1, 佐々木奈々1, 水谷信介1, 中山理祐子1, 清田実希1, 内山人二1, 松本洋典1, 島崎千尋2, 堀池重夫1, 谷脇雅史1 International Journal of Myeloma (suppl): 68-68, 2010. |
---|
![]() |
Examination about the self-to-self safety that we preloaded that increased bell Quaid for the I-5 youth multiple myeloma 竹迫直樹1, 関口直宏1, 芳賀光洋1, 永田明久1, 能登俊1, 三輪哲義2 International Journal of Myeloma (suppl): 68-68, 2010. |
---|
![]() |
Evaluation of drug interaction and the adverse event in the J-1 bortezomib chemotherapy 吉野真樹1, 田中佳美1, 長井春樹1, 五十嵐夏恵2, 廣瀬貴之2, 今井洋介2, 石黒卓朗2, 張高明2 International Journal of Myeloma (suppl): 69-69, 2010. |
---|
![]() |
Adverse event investigation of the bortezomib therapy for the J-2 multiple myeloma 根本真記1, 川上和宜1, 照井康仁2, 濱敏弘1 International Journal of Myeloma (suppl): 69-69, 2010. |
---|
![]() |
Development future with having seen it from experience of the management of J-3 Revlimid 杉田真理子1, 松原利行1, 吉田喬2 International Journal of Myeloma (suppl): 70-70, 2010. |
---|
![]() |
Problems in a characteristic of peripheral neuropathy (PN) by the K-1 bortezomib and the evaluation 久保江利佳1, 水上久美子1, 山倉昌之2, 大沼洋子1, 末永孝生2 International Journal of Myeloma (suppl): 70-70, 2010. |
---|
![]() |
Effect by the brochure instruction to the patients receiving K-2 bell Quaid therapy 畑文子, 徳田恵, 城内祐美子, 遠藤千賀子, 晝澤征子 International Journal of Myeloma (suppl): 71-71, 2010. |
---|
![]() |
Comparison of awareness, the visible symptom evaluation of the peripheral neuropathy evaluation in the K-3 bortezomib administration 細川舞1, 磯田淳2, 眞中章弘3, 馬渡桃子2, 中橋寛隆2, 神尾直2, 松本守生2, 星野まち子1, 澤村守夫2 International Journal of Myeloma (suppl): 71-71, 2010. |
---|
![]() |
Examination by role cancellation, discontinuation, the weight loss reason of the nurse of the foreign chemotherapy room in the K-4 bortezomib therapy 松井優子, 高堂祥子, 前田冨美子, 寺西純子, 苗代真理子 International Journal of Myeloma (suppl): 72-72, 2010. |
---|